COVID-19 vaccines
E123479
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
All labels observed (5)
| Label | Occurrences |
|---|---|
| COVID-19 vaccine | 2 |
| COVID-19 | 1 |
| COVID-19 vaccines canonical | 1 |
| SARS-CoV-2 | 1 |
| mRNA COVID-19 vaccines | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1078010 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: COVID-19 vaccines Context triple: [Vaccine Education Center, hasTopic, COVID-19 vaccines]
-
A.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
B.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
C.
Vaccine Education Center
The Vaccine Education Center is a program at the Children's Hospital of Philadelphia that provides evidence-based information to the public about vaccines, vaccine safety, and immunization practices.
-
D.
Global Vaccine Action Plan
The Global Vaccine Action Plan is a comprehensive international framework developed to improve access to vaccines and strengthen immunization systems worldwide, guiding countries toward disease prevention and eradication goals.
-
E.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: COVID-19 vaccines Target entity description: COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
-
A.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
B.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
C.
Vaccine Education Center
The Vaccine Education Center is a program at the Children's Hospital of Philadelphia that provides evidence-based information to the public about vaccines, vaccine safety, and immunization practices.
-
D.
Global Vaccine Action Plan
The Global Vaccine Action Plan is a comprehensive international framework developed to improve access to vaccines and strengthen immunization systems worldwide, guiding countries toward disease prevention and eradication goals.
-
E.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
- F. None of above. chosen
Statements (54)
| Predicate | Object |
|---|---|
| instanceOf |
medical intervention
ⓘ
pharmaceutical product ⓘ vaccine class ⓘ |
| administeredBy | intramuscular injection ⓘ |
| commonSideEffect |
chills
ⓘ
fatigue ⓘ fever ⓘ headache ⓘ injection site pain ⓘ muscle pain ⓘ |
| contributesTo | herd immunity against COVID-19 ⓘ |
| developedDuring | COVID-19 pandemic ⓘ |
| effectOnTransmission | reduction of SARS-CoV-2 transmission risk ⓘ |
| effectOnVariants | reduced effectiveness against some variants compared with ancestral strain ⓘ |
| firstWidespreadUse | 2020 ⓘ |
| globalDistribution | administered in most countries worldwide ⓘ |
| hasType |
DNA vaccine
ⓘ
inactivated virus vaccine ⓘ mRNA vaccine ⓘ protein subunit vaccine ⓘ viral vector vaccine ⓘ virus-like particle vaccine ⓘ |
| indication |
prevention of COVID-19-related death
ⓘ
prevention of COVID-19-related hospitalization ⓘ prevention of severe COVID-19 ⓘ prevention of symptomatic COVID-19 ⓘ |
| mechanismOfAction |
induction of adaptive immune response
ⓘ
stimulation of T-cell response against SARS-CoV-2 ⓘ stimulation of antibody production against SARS-CoV-2 ⓘ |
| publicHealthRole | key tool in COVID-19 pandemic control ⓘ |
| purpose |
prevention of COVID-19 infection
ⓘ
reduction of COVID-19 hospitalization ⓘ reduction of COVID-19 mortality ⓘ reduction of severe COVID-19 ⓘ |
| rareAdverseEvent |
anaphylaxis
ⓘ
myocarditis ⓘ pericarditis ⓘ thrombosis with thrombocytopenia syndrome ⓘ |
| recommendedBy |
European Centre for Disease Prevention and Control
ⓘ
Centers for Disease Control and Prevention ⓘ
surface form:
U.S. Centers for Disease Control and Prevention
World Health Organization ⓘ |
| regulatoryApproval |
Conditional Marketing Authorization by European Medicines Agency
ⓘ
Emergency Use Authorization by U.S. FDA ⓘ Emergency Use Listing by WHO ⓘ |
| storageRequirement |
refrigeration for many products
ⓘ
ultra-cold chain for some mRNA vaccines ⓘ |
| subjectOf |
large-scale clinical trials
ⓘ
post-marketing safety surveillance ⓘ |
| targetDisease |
COVID-19 pandemic
ⓘ
surface form:
COVID-19
|
| targetPathogen | SARS-CoV-2 ⓘ |
| typicalSchedule |
primary series plus booster doses
ⓘ
single-dose primary series for some products ⓘ two-dose primary series for many products ⓘ |
| updatedFormulation | variant-adapted vaccine ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: COVID-19 vaccines Description of subject: COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
Referenced by (6)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
COVID-19
this entity surface form:
SARS-CoV-2
this entity surface form:
mRNA COVID-19 vaccines
this entity surface form:
COVID-19 vaccine
this entity surface form:
COVID-19 vaccine